MedTrace Logo

Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children

NCT00810862 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2008-12-18

No results posted yet for this study

Summary

Primecrolimus cream 1% is effective in the treatment of atopic dermatitis in African American children.

Conditions

Interventions

DRUG

pimecrolimus active cream

Pimecrolimus 1% cream apply to affected study area twice daily for 21 days

OTHER

placebo base cream

apply to affected study area twice daily for 21 days

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2008-06-30
Completion
2008-06-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00810862 on ClinicalTrials.gov